Diabetes News

Adults who develop new-onset type 2 diabetes may have increased risk for obesity-related cancers compared with those without type 2 diabetes, though associations vary between men and women, according to new data.

NEW ORLEANS — Patients with type 2 diabetes who switched to tirzepatide rather than escalating their dulaglutide dosage had greater weight loss and improved glucose control, new data showed.

Men who have a sister with polycystic ovary syndrome are more likely to develop hypertension, obesity and type 2 diabetes than men who do not have a sister with PCOS, according to data from Sweden.

Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent metabolic and bariatric surgery, according to study results published in JAMA Surgery.

An advanced hybrid closed-loop insulin delivery system is safe to use for pregnant women with type 1 diabetes and may provide some glycemic benefits, especially during overnight hours, according to a presenter.

CHICAGO — Among patients with diabetes and peripheral artery disease, semaglutide 1 mg increased walking distance vs. placebo, according to data from the STRIDE trial presented at the American College of Cardiology Scientific Session.

Patients with type 1 diabetes initiating automated insulin delivery had a significantly lower HbA1c at 13 weeks than those receiving multiple daily insulin injections, according to a presenter.

The future of the landmark Diabetes Prevention Program is in doubt after it lost federal funding for an ongoing long-term outcomes study and was forced to stop operations, according to the chair of the program.

A 15-day integrated continuous glucose monitor registered accurate glucose values similar to those measured through venous blood samples, according to a presenter.